Immunogenicity of a protective whole cell mycobacterial vaccine in HIV-infected adults: A phase III study in Tanzania-Reference-Cited by-同舟云学术

Immunogenicity of a protective whole cell mycobacterial vaccine in HIV-infected adults: A phase III study in Tanzania

Published:2010-11 Issue:48 Volume:28 Page:7652-7658
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Lahey Timothy,Arbeit Robert D.,Bakari Muhammad,Horsburgh C. Robert,Matee Mecky,Waddell Richard,Mtei Lillian,Vuola Jenni M.,Pallangyo Kisali,von Reyn C. Fordham

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference49 articles.

1. Protective vaccination against tuberculosis with special reference to BCG vaccination;Aronson;Am Rev Tuberc,1948

2. BCG vaccination of infant Indians in Saskatchewan;Ferguson;Tubercle,1949

3. BCG vaccination in tuberculous households;Rosenthal;Am Rev Respir Dis,1960

4. BCG vaccination against tuberculosis in Chicago: a twenty year study statistically analyzed;Rosenthal;Pediatrics,1961

5. Results of BCG immunization in New York City;Levine;Am Rev Tuberc,1948

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Developing tuberculosis vaccines for people with HIV: consensus statements from an international expert panel;The Lancet HIV;2022-11

2. Pathological and protective roles of dendritic cells in Mycobacterium tuberculosis infection: Interaction between host immune responses and pathogen evasion;Frontiers in Cellular and Infection Microbiology;2022-07-28

3. An Update on Tuberculosis Vaccines;Vaccine Design;2021-12-17

4. Rapidly Growing Mycobacterium Species: The Long and Winding Road from Tuberculosis Vaccines to Potent Stress-Resilience Agents;International Journal of Molecular Sciences;2021-11-29

5. DAR-901 vaccine for the prevention of infection with Mycobacterium tuberculosis among BCG-immunized adolescents in Tanzania: A randomized controlled, double-blind phase 2b trial;Vaccine;2020-10